Introduction {#Sec1}
============

The frontline function of phagocytes such as neutrophils and macrophages in our innate immune defense has been classically understood to reflect a variety of potent intracellular microbicidal mechanisms. Upon contact with the invading pathogen, phagocytes engulf the microbes into their phagocytic vacuoles (phagosomes). Efficient uptake is facilitated through prior opsonization of the microbe with circulating complement or, in the nonnaïve host, specific antibodies recognizing epitopes on the pathogen surface. Phagosomes subsequently fuse with intracellular granules to form the phagolysosome, within which microbial killing is achieved by a combination of nonoxidative and oxidative mechanisms \[[@CR1], [@CR2]\]. Potent nonoxidative killing mechanisms include antimicrobial peptides (AMPs) such as cathelicidins and defensins and the activities of cathepsins and other degradative proteases; the oxygen-dependent "respiratory burst" involves the nonmitochondrial generation of antimicrobial reactive oxygen species (ROS) through the membrane-bound NADPH oxidase enzyme complex.

However, beginning with a landmark study in 2004 \[[@CR3]\], the fundamental conception of how, and *where*, neutrophils kill pathogenic microbes has been altered in a most fascinating and provocative way. The discovery of DNA-based antimicrobial extracellular traps (ETs) elaborated by neutrophils (NETs) has important implications for our understanding of the innate immune system and the pathophysiology of infectious and inflammatory diseases. And with recent data indicating that this phenomenon is not restricted to neutrophils but shared by other specialized leukocytes, one has the sense that we are at the inception of a major field of investigation whose ramifications may be quite far-reaching. Here, we summarize current knowledge of ETs and their functions in innate host defense.

Neutrophil extracellular traps {#Sec2}
==============================

The phenomenon of NETs, as well as their basic structure and function, was first discovered by Brinkmann et al. using electron microscopy \[[@CR3]\]. NETs were observed as a highly decondensed chromatin structure that is formed and released by activated neutrophils. Since treatment with DNase led to the disintegration of NETs, DNA was ascertained to represent the major structural component ---a backbone upon which histones, proteases (e.g. elastase), and AMPs reside. The fibrous DNA stretches within NETs had a diameter of 15--17 nm, punctuated with globular protein domains ranging from \~25 nm up to large aggregates of \~50 nm. It was surmised that the cationic proteins embedded within the NETs such as histones or cathelicidin AMPs confer an ability to kill entrapped microbes. This concept was validated when efficient killing of bacteria such as *Staphylococcus aureus* and *Listeria monocytogenes* by neutrophils occurred even when phagocytosis was blocked pharmacologically (cytochalasin D, an actin microfilament inhibitor). Moreover, this extracellular antimicrobial activity was eliminated by DNase treatment and dissolution of the NET architecture \[[@CR3]\]. Our own three-dimensional confocal micrograph of *S*. *aureus* entrapped within human NETs is presented in Fig. [1](#Fig1){ref-type="fig"}. Fig. 1Bacterial entrapment in NETs: three-dimensional confocal micrograph of FITC-labeled *S*. *aureus* (strain Cowan) entrapped by human neutrophil extracellular traps, as visualized by the blue DNA dye DAPI

A variety of different proinflammatory stimuli have been shown to activate the formation of ETs (Table [1](#Tab1){ref-type="table"}), including hydrogen peroxide (H~2~O~2~), bacterial lipopolysaccharide (LPS), the mitogen phorbol myristate acetate (PMA), and the CXC family chemokine interleukin 8 (IL-8) \[[@CR3], [@CR4]\]. The chemotactic complement-derived peptide complement factor 5a (C5a) can also stimulate NET formation but only after mature neutrophils are primed with interferons or granulocyte macrophage colony-stimulating factor (GM-CSF) \[[@CR5]\]; no such priming step is required for NET induction with LPS, PMA, or IL-8 \[[@CR3]\]. Platelets activated in a TLR4-dependent fashion can also induce NETs, promoting the trapping of bacteria within blood vessels \[[@CR6]\]. And as would befit a critical innate immune process, direct exposure to a variety of different microbial pathogens is sufficient to trigger NET formation, including *S*. *aureus* \[[@CR4]\], *Streptococcus pyogenes* \[[@CR7]\], *Mycobacterium tuberculosis* \[[@CR8]\], *Escherichia coli* \[[@CR9]\], hyphae or yeast forms of *Candida albicans* \[[@CR10]\], and the protozoan parasite *Leishmania amazonensis* \[[@CR11]\]. Studies with *C*. *albicans* suggest that prior opsonization of the pathogen can increase the NET response \[[@CR10]\]. Recently, an individual bacterial protein, the surface-anchored and soluble M1 protein of *S*. *pyogenes*, was found sufficient to induce NET formation \[[@CR12], [@CR13]\], adding to its described proinflammatory properties \[[@CR14]\]. Surface lipophosphoglycan purified from *L*. *amazonensis* is also capable of inducing nets in a dose-dependent fashion \[[@CR11]\]. Table 1Factors or microbes inducing formation of extracellular trapsFactor or MicrobeCellular origin of extracellular trapReferencesInterleukin 8 (IL-8)Neutrophils\[[@CR3]\]Lipopolysaccharide (LPS)Neutrophils\[[@CR3]\]Phorbol myristate acetate (PMA)Neutrophils, mast cells\[[@CR3], [@CR21]\]Hydrogen peroxideNeutrophils, mast cells\[[@CR4], [@CR21]\]Platelet TLR-4Neutrophils\[[@CR6]\]Interferon (IFN) γ + C5aNeutrophils, eosinophils\[[@CR5], [@CR32]\]Interferon (IFN) γ + LPSEosinophils\[[@CR32]\]Interferon (IFN) γ + eotaxinEosinophils\[[@CR32]\]IL-5 + LPS/C5a/eotaxinEosinophils\[[@CR32]\]Interferon (IFN) α + C5aNeutrophils\[[@CR5]\]GM-CSF + C5aNeutrophils\[[@CR5]\]*Staphylococcus aureus*Neutrophils, mast cells\[[@CR4], [@CR21]\]*Streptococcus pyogenes*Neutrophils, mast cells\[[@CR7], [@CR21]\]*Streptococcus pyogenes*M1 protein--fibrinogen complexNeutrophils, mast cells\[[@CR12], [@CR13]\]*Pseudomonas aeruginosa*Mast cells\[[@CR21]\]*Mycobacterium tuberculosis*Neutrophils\[[@CR8]\]*Mycobacterium canettii*Neutrophils\[[@CR8]\]*Candida albicans* (hyphae or yeast)Neutrophils\[[@CR10]\]*Escherichia coli*Neutrophils\[[@CR9]\]*Leishmania amazonensis*Neutrophils\[[@CR11]\]*Leishmania amazonensis*, surface lipophosphoglycanNeutrophils\[[@CR11]\]

Knowledge is beginning to emerge regarding the cellular processes that precede the formation of NETs by activated neutrophils (summarized in Fig. [2](#Fig2){ref-type="fig"}). Evidence implicates the production of ROS such as superoxide (O~2~^−^) or H~2~O~2~ as an essential signal leading to the induction of unique cell death program and the elaboration of NETs \[[@CR4]\]. Interference with ROS generation using diphenylene iodonium (DPI), an inhibitor of NADPH oxidase enzymes, blocks the formation of NETs. This process is morphologically distinct from other classical cell death processes including apoptosis and necrosis and hence was dubbed "NETosis" \[[@CR15]\]. One key biochemical marker of NET formation appears to be the deimination of arginine residues in histones to citrullines, a posttranslational modification catalyzed by peptidyl arginine deaminase that aids in chromatin decondensation. Hypercitrullinated histones were detected in NETs released by neutrophils activated by LPS and H~2~O~2~ but not in neutrophils treated with staurosporine or camptothecin to induce apoptosis \[[@CR16], [@CR17]\]. Fig. 2Model for formation of neutrophil extracellular traps. Neutrophils are activated by contact with microbial pathogens different stimuli such as LPS, IL-8, PMA, IFN-α/γ + C5a or GM-CSF + C5a. Stimulation of neutrophils results in the activation of NADPH oxidases and the formation of reactive oxygen species (ROS). ROS signaling is required for the novel cell death pathway of ETosis, which is characterized by the disruption of the nuclear membrane, chromatin decondensation, and the mixing of nuclear contents with cytoplasmic and granular proteins. As a final step, nuclear and granular components are released by the dead cell generating the extracellular traps. Extracellular traps have the ability to entrap and/or kill different microbes, while also enhancing proinflammatory innate immune responses

In NETosis, global chromatin decondensation and disintegration of the nuclear membrane occurs concomitant with cytoplasmic granule dissolution, allowing the NET components to mix in the cytoplasm prior to their extracellular release \[[@CR4], [@CR15]\]. The negatively charged DNA backbone of NETs also provides a framework for activation of the contact system \[[@CR13]\], which is comprised of the serum-derived serine proteases factor XI, factor XII, and plasma kallikrein together with the nonenzymatic high-molecular-weight cofactor, kininogen \[[@CR18]\]. Activation of the contact system results in generation of the potent proinflammatory mediator bradykinin, as well as breakdown peptide fragment of HK with potent antimicrobial properties \[[@CR19]\]. The humoral pattern recognition receptor pentraxin 3 is also present in neutrophil-specific granules and localizes to NETs where it may play a role in the control of fungal pathogens such as *Aspergillus fumigatus* \[[@CR20]\].

Mast cell extracellular traps {#Sec3}
=============================

ET formation was first thought to be restricted to neutrophils, as stimulation of peripheral blood mononuclear cells with PMA or H~2~O~2~ did not induce release of similar DNA-based extracellular structures \[[@CR4]\]. However, recent investigations have revealed that another tissue granulocyte important to innate host defense, the mast cell (MC), is also able to elaborate its nuclear DNA to produce antimicrobial ETs \[[@CR21]\].

MCs are prevalent at sites interfacing with the environment such as the respiratory tract and skin. Largely studied in the context of allergic diseases \[[@CR22]\], the role of MCs in host defense against bacterial pathogens has attracted increasing attention \[[@CR23]\]. MCs prestore tumor necrosis factor α in their secretory basophilic granules, which can be released immediately upon activation by pathogens to promote early neutrophil recruitment and bacterial clearance \[[@CR24]\]. MCs have also been shown to directly kill bacteria after intracellular uptake through oxidative and nonoxidative antimicrobial mechanisms, similar to traditional phagocytes such as neutrophils and macrophages \[[@CR25]\]. Potent broad-spectrum AMPs such as cathelicidin and β-defensins are present in MC granules and are secreted upon bacterial stimulation \[[@CR26], [@CR27]\].

Recently, confocal fluorescent microscopy and scanning electron microscopy were used to demonstrate that both human and murine MCs exert extracellular antimicrobial activity through ROS-dependent dissolution of the nuclear membrane and elaboration of structures that strongly resembled NETs \[[@CR21]\]. Mast cell extracellular trap (MCET) production was documented in response to various pathogens including *S*. *aureus*, *Pseudomonas aeruginosa*, and *S*. *pyogenes* \[[@CR21]\] and, like NET formation, in response to the purified M1 protein of *S*. *pyogenes* \[[@CR12]\]. The major components of human MCETs are DNA, histones, MC-specific granule proteins such as tryptase, and the cathelicidin AMP LL-37. Bacterial entrapment was required for antimicrobial activity since dismantling the MCETs structure strongly reduced bacterial killing \[[@CR21]\]. However, in contrast to NETs, DNase alone was not sufficient to dismantle MCETs; additional treatment with tryptase-degrading myeloperoxidase was required for this purpose. Wartha and Henriques-Normark \[[@CR28]\] have recently recommended recoining the term "NETosis" to "ETosis," consistent with the relevance of this phenomenon for additional cell types.

Catapulting mitochondria and eosinophil extracellular traps {#Sec4}
===========================================================

Eosinophils, sharing many similarities with MC, are a specialized and rather enigmatic granulocytic cell type derived from the bone marrow. Generally residing in hematopoietic and lymphatic organs such as the spleen and lymph nodes \[[@CR29]\], eosinophils can also infiltrate stomach, small intestine, and colon, where they are seen in association with inflammatory bowel disease (IBD) and a spectrum of conditions now known as eosinophil-associated gastrointestinal disorders (EGIDs) \[[@CR30], [@CR31]\]. Although the reliable induction of eosinophil counts in response to parasitic nematode infections suggest they serve an immune role, the exact function(s) of eosinophils in host defense have remained unclear.

However, very recently, Yousefi et al. identified a remarkable phenomenon of catapult-like ejection of mitochondrial DNA by eosinophils with the potential to contribute to antibacterial defense \[[@CR32]\]. Examining infectious foci from biopsies of patients with IBD or intestinal spirochetosis, the authors observed DNA-containing material extruding from gastrointestinal eosinophils. The authors then showed that, when blood eosinophils were primed in vitro with IL-5 or interferon γ (IFN- γ) and subsequently stimulated with LPS, C5a, or the eosinophil chemokine eotaxin, they would release mitochondrial (but not nuclear) DNA, thus forming extracellular traps containing antibacterial eosinophilic cationic protein and major basic protein \[[@CR32]\]. Similar to NETs and MCETs, treatment with DNase resulted in the disappearance of the eosinophil-derived extracellular DNA structures and in the abolishment of extracellular bacterial killing.

Like NETs and MCETs, the eosinophil ET process is dependent on ROS production but importantly does not represent a specialized form of cell death since the eosinophil remains viable after ejection of its mitochondrial DNA (differences highlighted in Table [2](#Tab2){ref-type="table"}). A role in defense of compromised gastrointestinal epithelium is postulated, and transgenic hypereosinophilic mice were shown to be less susceptible to septicemia following cecal ligation puncture \[[@CR32]\]. However, the in vivo function of eosinophil-derived ETs remains to be demonstrated, and it is at least conceivable that the release of proinflammatory eosinophil contents represents part of the underlying pathophysiology of IBD and EGID, as opposed to an adaptive antibacterial defense mechanism \[[@CR33]\]. Table 2Comparison of formation of extracellular traps by different cell typesNeutrophilsMast cellsEosinophilsMain backboneDNADNA, tryptaseDNADegradation of trapsDNaseDNase (tryptase-degrading) myeloperoxidaseDNaseFurther identified componentsHistones, elastase, myeloperoxidase, cathepsin G, LL-37, PTX-3, gelatinase, lactoferrin, bactericidal permeability increasing protein (BPI), peptidoglycan recognition proteins (PGRPs)Histones, LL-37Eosinophilic cationic protein (ECP), major basic protein (MBP)Final cell statusDeadDeadAliveROS dependentYesYesYesOrigin of DNANuclearNuclearMitochondrialDisruption of nuclear membraneYesYesNoTime frame10 min to 4 h10 min to 4 hSeconds

Association of ETs with specific disease conditions {#Sec5}
===================================================

There is increasing evidence that ETs play an important role in several infectious as well as noninfectious diseases (Table [3](#Tab3){ref-type="table"}). The literature to date has demonstrated how a variety of microbes are entrapped within and/or killed by ET: Gram-positive bacteria (*S. aureus*, *S. pyogenes*, *S. pneumoniae*, *L. monocytogenes*), Gram-negative bacteria (*E. coli*, *Salmonella enterica*, *Shigella flexneri*, *Haemophilus influenzae*, *Pseudomonas luminescens*), mycobacteria (*M. tuberculosis*), fungi (*C*. *albicans*), and parasites (*L. amazonensis*). It remains uncertain whether viruses are entrapped by ETs. The molecular mechanisms involved in entrapment of the microbes are not known, but it is postulated that electrostatic interactions between the cationic component of NETs and the anionic surface of microorganisms play a role in this process \[[@CR34]\]. After disruption of extracellular traps with DNase or DNase/proteinase mixtures, the extracellular antimicrobial activity of neutrophils, eosinophils, or MCs is eliminated \[[@CR4], [@CR21], [@CR32]\]. Table 3Association of extracellular traps with diseasesInfectious diseaseRole of extracellular trapsReferences*Staphylococcus aureus*Capture and kill bacteria\[[@CR3]\]*Streptococcus pyogenes*Capture and kill bacteria\[[@CR7]\]*Streptococcus pneumoniae*Capture and prevent spreading of bacteria\[[@CR37]\]*Salmonella enterica* serovar TyphimuriumCapture and kill bacteria\[[@CR3]\]*Shigella flexneri*Capture and kill bacteria\[[@CR3]\]*Escherichia coli*Capture and kill bacteria\[[@CR9]\]*Candida albicans*Capture and kill hyphae or yeast\[[@CR10]\]*Mycobacterium tuberculosis*Capture bacteria\[[@CR8]\]*Mycobacterium canettii*Capture bacteria\[[@CR8]\]*Listeria monocytogenes*Capture and kill bacteria\[[@CR8]\]*Haemophilus influenzae*Biofilm formation and persistence\[[@CR36]\]*Photorhabdus luminescens*Capture and kill bacteria\[[@CR53]\]*Plasmodium falciparum*Unclear\[[@CR35]\]Intestinal spirochetosisUnclear\[[@CR32]\]*Leishmania amazonensis*Capture and kill parasite\[[@CR11]\]Bacterial sepsisUpon platelet activation, potential endothelial injury\[[@CR6]\]Noninfectious diseaseAppendicitisUnclear\[[@CR3]\]Human preeclampsiaEntrap and control release of proinflammatory placenta-derived syncytiotrophoblast microparticles (STBM)\[[@CR44]\]Infertility of horsesEntrapment of sperm cells\[[@CR54]\]Autoimmune reactionsUnclear\[[@CR3], [@CR16]\]

Several studies have provided in vivo demonstrations of ET formation during infection, including spontaneous human appendicitis \[[@CR3]\], children with *Plasmodium falciparum* malaria \[[@CR35]\], patients with cutaneous leishmaniasis \[[@CR11]\], *Shigella*-induced experimental dysentery in rabbits \[[@CR3]\], *H. influenzae*-associated otitis media in chinchillas \[[@CR36]\], murine models of pneumococcal pneumonia \[[@CR37]\], *S. pyogenes* necrotizing soft tissue infection \[[@CR7]\], and polymicrobial sepsis after cecal ligation and puncture \[[@CR32]\]. Recently, NETs were also detected in bovine mastitis induced by pathogenic *E. coli*, where neutrophil phagocytosis and oxidative burst have been shown to be hampered by milk fat, proteins, or hyperketonemia \[[@CR9], [@CR38]\].

If ETs indeed serve a critical innate immune function, then deficiencies in ET formation would be postulated to render the individual host more susceptible to infection. Some evidence is beginning to emerge along these lines. For example, human newborns are known to have qualitative defects in neutrophil function that contribute to sepsis and other infectious complications. Yost et al. recently demonstrated that neutrophils from term and preterm infants fail to form NETs when activated by inflammatory agonists that readily stimulate NET formation in adult neutrophils (e.g., LPS, PMA); consequently, a defect in the ability of the newborn neutrophils to carry out extracellular bacterial killing is appreciated \[[@CR39]\]. Neutrophils and eosinophils from individuals with chronic granulomatous disease, an hereditary dysfunction of NADPH oxidase function and respiratory burst, are unable to form neutrophil or eosinophil extracellular traps \[[@CR4], [@CR32]\], an observation that might further explain the marked susceptibility of these patients to recurrent life-threatening bacterial and fungal infections \[[@CR40]\].

ETs are now recognized to be present in certain noninfectious diseases, as summarized in Table [2](#Tab2){ref-type="table"}. NETs are also produced during sepsis after platelet-mediated neutrophil activation, and, though contributing to bacterial entrapment, the accumulation of NETs and their component proteases may promote vascular endothelial injury and ischemia \[[@CR6]\]. Preeclampsia, a potentially life-threatening pregnancy-related disorder, is characterized by neutrophil activation and a previously unexplainable high level of circulatory DNA of maternal origin \[[@CR41]--[@CR43]\]. In this scenario, NETs were able to entrap proinflammatory syncytiotrophoblast microparticles and thereby possibly control the immune response by keeping inflammatory mediators from diffusing to adjacent healthy tissue \[[@CR44]\]. Such a function for MCETs, i.e., to minimize collateral tissue damage by sequestering harmful compounds of MC granules such as proteolytic enzymes or histamines at the site of infection, has also been postulated \[[@CR21]\].

It is interesting to speculate that dysregulated leakage of nucleic acids from neutrophils or MC or perhaps the failure of the host to efficiently clear ETs after their induction may have detrimental consequences leading to autoimmune phenomenon as seen in lupus erythematosus, where antibodies directed against nucleic acids and histones are a pathognomonic feature \[[@CR3]\]. Recently, Neeli et al. \[[@CR16]\] showed that deiminated histones, a covalently modified form of a prominent nuclear autoantigen, are released to the extracellular space as part of formation of NETs. The authors hypothesized that the possible association of a modified autoantigen with microbial components could, in predisposed individuals, increase the risk of autoimmunity \[[@CR16]\]. In *P. falciparum* malaria, circulating neutrophil-derived ETs bearing adherent parasites and erythrocytes are seen in concert with antinuclear immunoglobulin G. However, since a genetic model to eliminate expression of NETs or MCETs has not been realized, verification of the full contribution(s) of ETs to infectious, noninfectious, or autoimmune diseases remains challenging.

Mechanisms of microbes to avoid entrapment or killing by ETs {#Sec6}
============================================================

Perhaps the best evidence for a critical role of ETs in innate host defense has come from recent experimentation manipulating the microbial side of the host--pathogen equation. These studies have shown that certain leading bacterial pathogens have evolved mechanisms to avoid ET-based immune clearance, either through ET degradation, resistance to the intrinsic antimicrobial effectors with ETs, or the suppression of ET production (summarized in Table [4](#Tab4){ref-type="table"}). Table 4Mechanisms of microbes to avoid entrapment/killing in extracellular trapsMicrobeEvasion strategyReferences*Streptococcus pyogenes*NET degradation by DNase Sda1/2\[[@CR7], [@CR45]\]*Streptococcus pyogenes*Reduction of NET production by IL-8 protease SpyCEP\[[@CR51]\]*Streptococcus pyogenes*Resistance against LL-37-mediated killing within NETs/MCETs by surface M1 protein\[[@CR12]\]*Streptococcus pneumoniae*NET-degradation by DNase EndA\[[@CR37]\]*Streptococcus pneumoniae*Preventing entrapment within NETs by capsule (serotype 1, 2, 4, 9 V) and D-alanylated lipoteichoic acids (LTA)\[[@CR48]\]*Haemophilus influenzae*Resistance against NET-killing by surface lipooligosaccharides\[[@CR36]\]*Streptococcus agalactiae*Suppression of NETs by sialic acid engagement of Siglec receptors and consequent inhibitory signaling\[[@CR52]\]

Shortly after the discovery of NETs, several independent groups demonstrated the ability of pathogenic bacteria to avoid entrapment and killing by NETs by production of DNA-degrading nucleases. Targeted elimination of DNase production in *S. pyogenes*, and in particular the potent bacteriophage-encoded DNase Sda1, rendered the pathogen more susceptible to neutrophil extracellular killing \[[@CR7], [@CR45]\]; correspondingly, heterologous expression of Sda1 in other bacterial strains conferred an ability to degrade NETs and resist neutrophil killing \[[@CR7]\]. DNase-deficient GAS were attenuated for virulence in a murine necrotizing fasciitis model \[[@CR7], [@CR45]\], and pharmacological inhibition of DNase activity with G-actin provided a therapeutic benefit against GAS proliferation and tissue damage \[[@CR7]\]. Acquisition of the bacteriophage encoding Sda1, and its upregulation during the genetic and phenotypic switch to the invasive phenotype \[[@CR46]\], may help explain the global dissemination of a hypervirulent clone of M1 serotype *S. pyogenes* associated with severe human infections including necrotizing fasciitis \[[@CR47]\]. Similar mutagenesis studies elegantly demonstrated that production of the DNase EndA by *S. pneumoniae* could degrade NETs, promote bacterial resistance to neutrophil killing, and contribute to virulence in a murine model of pneumococcal pneumonia \[[@CR37]\].

*S. pneumoniae* expression of polysaccharide capsule, a classical virulence factor of the pathogen, significantly reduced the trapping of the bacterium within NETs, providing another potential mechanistic contribution of capsule to disease progression \[[@CR48]\]. Cationic antimicrobial peptides such as cathelicidin are important effectors of bacterial killing within NETs. *S. pneumoniae* mutants lacking positively charged [d]{.smallcaps}-alanyl residues of their surface lipoteichoic acid (LTA) were more susceptible to killing by NET components, suggesting that these gene-encoded surface modifications are important for survival, especially in settings of low encapsulation \[[@CR48]\]. D-alanylation of LTA by the *dlt* operon is known to contribute to resistance of *S. pyogenes* \[[@CR49]\] and *S. aureus* \[[@CR50]\] to cathelicidin antimicrobial peptides, which in turn are localized within NETs. Recently, it was shown that the surface-expressed M1 protein of *S. pyogenes* is able to bind cathelicidin LL-37 and prevent its bactericidal activity and, as a result, promote GAS survival within NETs and MCETs \[[@CR12]\]. Nontypeable *H. influenzae*, a major etiologic agent of middle ear infections, expresses key lipooligosaccharide moieties that promote biofilm formation and allow the organism to survive within NETs in the middle ear cavity \[[@CR36]\].

The inhibition of NET production provides a proximal means for pathogen avoidance of neutrophil extracellular killing. The chemokine IL-8, released by epithelial cells at the focus of infection and by recruited neutrophils themselves in amplifying the immune response, is a potent inducer of NET formation \[[@CR4], [@CR44]\]. *S. pyogenes* expresses a peptidase, SpyCEP, which cleaves and inactivates IL-8. Expression of SpyCEP was shown to reduce the level GAS-stimulated NET production and thus help the pathogen evade neutrophil extracellular killing \[[@CR51]\]. *Streptococcus agalactiae*, a major cause of invasive infections in human newborns, expresses an exopolysaccharide capsule containing terminal sialic acid residues mimicking a common glycoepitope on human cell surfaces. It was recently shown that *S. agalactiae* can engage Siglec receptors on human neutrophils via these sialic acid moieties, leading to negative cell signaling, suppression of the oxidative burst, and diminished NET production, thereby promoting resistance to neutrophil killing \[[@CR52]\].

Summary {#Sec7}
=======

The process of microbial phagocytosis by white blood cells was originally described by the Russian microbiologist Ilya Metchnikov, a discovery for which he was awarded the Nobel Prize in Medicine or Physiology just over a century ago. The recent discoveries summarized herein of DNA-based ETs dramatically expand the antimicrobial repertoire of these highly specialized leukocytes and thus extend the playing field on which the battle against pathogens is fought from the intracellular to the extracellular compartment. The tenacious constituency of pus generated at primary foci of infection following neutrophil infiltration can now be viewed as a more physiologic and purposeful phenomenon---an immunological quicksand, so to speak, that serves to prevent spread and aid in sterilization by physically trapping microorganisms and directly exposing them to antimicrobial histones, peptides, and proteases. Leading human pathogens, it would seem, demonstrate mechanisms to avoid or escape ET that may be as pivotal to their virulence potential as resistance to phagocytosis; many more such ET survival capacities are certain to be discovered. And as for many other aspects of our immune defense, too much of a good thing can prove detrimental, and potential contributions of NETs to inflammatory and autoimmune diseases merit further exploration.
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